| Application no. and date | 15715192.9 (espacenet) (Federated) (European Patent Register), 20150326 | | Patent/reg. no. and date | DK/EP 3148529, 20211020 | | Publication date | 20170405 | | Priority no. and date | GB 201409471, 20140528 | | EP pub. no. and date |
EP 3148529 20170405 | | Effective date | | | Applicant/owner | Euro-Celtique S.A., 1, rue Jean Piret
2350 Luxembourg, LU | | Applicant ref. no. | V160686DK | | Inventor | MEHRLING, Thomas, c/o Mundipharma EDO GMBH
St. Alban Rheinweg 74
4052 Basel, CH,
FESTUCCIA, Claudio, c/o Department of Applied Clinical Sciences and
Biotechnologies
University of L'Aquila
Via Vetoio snc
Coppito
67100 L'Aquila, IT | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/395 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/502 (2006.01) , A61K 31/55 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | FORBINDELSER TIL BEHANDLING AF HJERNECANCER | | Int. application no. | EP2015056667 | | Int. publication no. | WO2015180865 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
